Pharma channel feed

Trump’s HHS de­fends Biden-era stance on 340B re­bate mod­els

Last month
Law

WuXi AppTec's US rev­enue growth con­tin­ues to dip in post-Biose­cure en­vi­ron­ment

Last month
China
Manufacturing

As­traZeneca re­ports Phase 3 suc­cess for rare dis­ease drug at heart of Amolyt deal

Last month
R&D

All se­lect­ed drug­mak­ers agree to sec­ond round of price ne­go­ti­a­tions un­der the IRA

Last month
FDA+

Post-Hoc: Kennedy's an­ti-vac­cine ac­tions should­n't sur­prise any­one

Last month
FDA+

Ot­suka's Tai­ho buys Swiss start­up Araris with three AD­Cs near­ing the clin­ic

Last month
Startups
Deals

Avid­i­ty seeks to 'set the stan­dard' as it heads to FDA with Duchenne drug

Last month
R&D

'It’s the law’: Dr. Oz says he would de­fend Medicare drug price ne­go­ti­a­tions

Last month
FDA+

Fed­er­al Cir­cuit rul­ing al­lows Am­gen's Eylea biosim­i­lar to stay on the mar­ket

Last month
Law

UK's plan to hike drug­mak­er re­bates re­flects 'bro­ken' sys­tem, phar­ma group says

Last month

Re­ci­pharm hits record rev­enue for 2024, eyes GLP-1 con­tracts for growth 

Last month
Manufacturing

RFK Jr. con­vened round­table around ways to re­duce stem cell reg­u­la­tion

Last month
Cell/Gene Tx

Sutro slash­es work­force in half, changes CEO and clos­es fac­to­ry

Last month
People
Manufacturing

Moon­Lake's CEO on its loom­ing mid-year piv­otal read­out in skin dis­ease

Last month

Pfiz­er ter­mi­nates an ear­ly-stage STING ag­o­nist tri­al

Last month
R&D

Up­dat­ed: White House pulls Wel­don's nom­i­na­tion to lead CDC at last minute

2 months ago
FDA+

Am­gen re­ports more Up­liz­na da­ta in myas­the­nia gravis ahead of FDA fil­ing

2 months ago
R&D

Re­searchers make case against Gilead in HIV prod­uct hop­ping fight

2 months ago
Law

Viking Ther­a­peu­tics taps Cor­den­Phar­ma to man­u­fac­ture its obe­si­ty drugs

2 months ago
Manufacturing

Leg­end to dou­ble Carvyk­ti pro­duc­tion as it tar­gets block­buster sta­tus 

2 months ago
Cell/Gene Tx
Manufacturing

Mer­ck scores a win in Gar­dasil cas­es af­ter judge says plain­tiffs’ ev­i­dence ‘falls far short’

2 months ago
Law

Cor­rect­ed: Mer­ck opens bil­lion-dol­lar US fa­cil­i­ty to make Gar­dasil

2 months ago
Manufacturing

Bris­tol My­ers buys out cell ther­a­py part­ner 2sev­en­ty bio

2 months ago
Deals
Cell/Gene Tx

BioN­Tech's shares dip af­ter post­ing luke­warm rev­enue guid­ance

2 months ago
First page Previous page 78910111213 Next page Last page
A service from the Financial Times